Exin Therapeutics vs Venture Builder AI: Revenue, Funding & Team Size Compared
Exin Therapeutics generates $550K in revenue; Venture Builder AI generates $550K. Exin Therapeutics and Venture Builder AI are close to the same size by revenue. The table below compares Exin Therapeutics and Venture Builder AI on funding, valuation, customers, team size and headquarters — every figure GetLatka has verified for each company.
| Company | ||
|---|---|---|
| Revenue | $550K | $550K |
| Team size | 5 | 5 |
| Founded | 2025 | 2024 |
| HQ | San Francisco, United States | United Kingdom |
Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews.
Exin Therapeutics at a glance
Exin Therapeutics generates $550K in revenue with 5 employees, headquartered in San Francisco, United States.
- Revenue
- $550K
- Team size
- 5
- Founded
- 2025
AI drug discovery platform for neurotherapeutics
Venture Builder AI at a glance
Venture Builder AI generates $550K in revenue with 5 employees, headquartered in United Kingdom.
- Revenue
- $550K
- Team size
- 5
- Founded
- 2024
Venture Builder AI is a scalable SaaS solution that uses AI to optimize business development processes. Designed for enterprises, accelerators, incubators, educational institutions, and private companies, it provides expert-driven guidance…
Other Exin Therapeutics alternatives
Exin Therapeutics competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category.
Exin Therapeutics vs Venture Builder AI: frequently asked questions
Is Exin Therapeutics or Venture Builder AI bigger?
Exin Therapeutics is the bigger company by revenue, at $550K against $550K for Venture Builder AI.
How much revenue does Exin Therapeutics make?
Exin Therapeutics generates $550K in annual revenue with a team of 5.
How much revenue does Venture Builder AI make?
Venture Builder AI generates $550K in annual revenue with a team of 5.